In-process characterization of human mesenchymal stem cells

Cell therapy products emerge from a long process of cell culture, differentiation and purification steps where appropriate cell identity and purity monitoring are mandatory. The characterization of human MSCs used for manufacturing of cell therapy products requires the development and the validation of analytical methods to encounter biopharmaceutical requirements.